Springfield, PA, United States of America

Christopher Larson


 


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 203(Granted Patents)


Location History:

  • Media, PA (US) (2011)
  • Springfield, PA (US) (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher Larson: Innovator in Tumor Cell Analysis

Introduction

Christopher Larson is a notable inventor based in Springfield, PA (US). He has made significant contributions to the field of medical diagnostics, particularly in the analysis of circulating tumor cells. With a total of 2 patents, Larson's work is pivotal in advancing cancer research and treatment methodologies.

Latest Patents

Larson's latest patents focus on the "Analysis of circulating tumor cells, fragments, and debris." The methods and reagents described in this invention are utilized to analyze circulating tumor cells, clusters, fragments, and debris. Analysis is performed using various platforms, including flow cytometry and the CellSpotter® fluorescent microscopy imaging system. Analyzing damaged cells is crucial, as there are two sources of damage: in vivo and in vitro. Damage in vivo occurs through apoptosis, necrosis, or immune response, while damage in vitro can happen during sample acquisition, handling, transport, processing, or analysis. Therefore, it is essential to confine, reduce, eliminate, or at least qualify in vitro damage to prevent it from interfering with analysis. The methods described herein are aimed at diagnosing, monitoring, and screening diseases based on circulating rare cells, including malignancy as determined by circulating tumor cells, clusters, fragments, and debris. Additionally, kits for assaying biological specimens using these methods are provided.

Career Highlights

Christopher Larson is currently associated with Veridex, LLC, where he continues to innovate in the field of tumor cell analysis. His work has been instrumental in developing techniques that enhance the accuracy and reliability of cancer diagnostics.

Collaborations

Larson collaborates with esteemed colleagues, including Galla Chandra Rao and Madeline I Repollet, to further advance research in this critical area of healthcare.

Conclusion

Christopher Larson's contributions to the analysis of circulating tumor cells represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts continue to pave the way for improved cancer detection and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…